Insulin aspart, recombinant Subcutaneous and Mefenamic acid
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mefenamic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mefenamic acid
Brand name: Ponstel
Synonyms: Mefenamic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Mefloquine
- Insulin aspart, recombinant Subcutaneous-Mefloquine Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Mefoxin
- Insulin aspart, recombinant Subcutaneous-Mefoxin Premixed
- Insulin aspart, recombinant Subcutaneous-Mega C Acid Plus
- Insulin aspart, recombinant Subcutaneous-Mega Zinc-100
- Mefenamic acid-Insulin degludec
- Mefenamic acid-Insulin Degludec (U-100) Prefilled Pens
- Mefenamic acid-Insulin Degludec (U-100) Vials
- Mefenamic acid-Insulin Degludec (U-200) Prefilled Pens
- Mefenamic acid-Insulin degludec and liraglutide
- Mefenamic acid-Insulin degludec and liraglutide Subcutaneous